<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03642912</url>
  </required_header>
  <id_info>
    <org_study_id>LMU 18-047</org_study_id>
    <nct_id>NCT03642912</nct_id>
  </id_info>
  <brief_title>Coagulation Monitoring in Patients on Extracorporeal Membrane Oxygenation (Observational Study)</brief_title>
  <official_title>Coagulation Monitoring in Patients on Extracorporeal Membrane Oxygenation Hämostaseologisches Monitoring Bei Patienten Mit Extrakorporaler Membranoxygenierung</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ludwig-Maximilians - University of Munich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ludwig-Maximilians - University of Munich</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Coagulation disorders are on top of the list of extracorporeal-membrane oxygenation (ECMO)
      complications. They contribute significantly to morbidity and mortality of ECMO patients.
      This observational study aims to evaluate coagulation profiles of ECMO patients treated on
      the intensive care units of the Department of Anaesthesiology of LMU Munich.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Coagulation disorders are on top of the list of extracorporeal-membrane oxygenation (ECMO)
      complications. They contribute significantly to morbidity and mortality of ECMO patients.
      This observational study aims to evaluate coagulation profiles of ECMO patients treated on
      the intensive care units of the Department of Anaesthesiology of LMU Munich. Adult ECMO
      patients are included in the study after informed consent.

      Bleeding and thromboembolic complications as well as treatment details are recorded.
      Additional coagulation laboratory markers (such as von-Willebrand-factor, ADAMTS13-protease,
      platelet function tests and thromboelastometric tests) are correlated with clinical signs of
      bleeding. Regular ultrasound examination of the large vessels are performed to Screen for
      thrombosis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 16, 2019</start_date>
  <completion_date type="Anticipated">May 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>platelet function parameter</measure>
    <time_frame>after starting ECMO therapy - up to 28 days after starting ECMO therapy</time_frame>
    <description>platelet function test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>platelet function parameter</measure>
    <time_frame>one week after ending ECMO therapy</time_frame>
    <description>platelet function test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>coagulation parameter</measure>
    <time_frame>after starting ECMO therapy - up to 28 days after starting ECMO therapy</time_frame>
    <description>thromboelastometric test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>coagulation parameter</measure>
    <time_frame>one week after ending ECMO therapy</time_frame>
    <description>thromboelastometric test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>inflammatory parameter</measure>
    <time_frame>after starting ECMO therapy - up to 28 days after starting ECMO therapy</time_frame>
    <description>bradykinin levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>inflammatory parameter</measure>
    <time_frame>one week after ending ECMO therapy</time_frame>
    <description>bradykinin levels</description>
  </secondary_outcome>
  <other_outcome>
    <measure>bleeding assessment</measure>
    <time_frame>after starting ECMO therapy - up to 28 days after starting ECMO therapy</time_frame>
    <description>all patients are screened for signs of bleeding or thrombosis</description>
  </other_outcome>
  <other_outcome>
    <measure>bleeding assessment</measure>
    <time_frame>one week after ending ECMO therapy</time_frame>
    <description>all patients are screened for signs of bleeding or thrombosis</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Coagulation and Hemorrhagic Disorders</condition>
  <condition>Extracorporeal Membrane Oxygenation Complication</condition>
  <arm_group>
    <arm_group_label>ECMO patients</arm_group_label>
    <description>ECMO patients treated on the intensive care units of the Department of Anesthesiology of LMU Munich</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        critically ill patients treated with ECMO
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient treated on ICU of Department of Anesthesiology of LMU Munich

          -  treated with ECMO

          -  age &gt;/= 18 years (adult patients only)

          -  informed consent

        Exclusion Criteria:

          -  underage patients

          -  pregnant patients

          -  hemoglobin level &lt; 8mg/dl
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Zoller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anaesthesiology, LMU Munich</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mathias Bruegel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Laboratory Medicine, LMU Munich</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dominik J Hoechter, MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Anaesthesiology, LMU Munich</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Weigand, MD</last_name>
    <role>Study Director</role>
    <affiliation>Institute of Laboratory Medicine, LMU Munich</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bernhard Zwißler, MD, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Anaesthesiology, LMU Munich</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Daniel Teupser, MD, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Institute of Laboratory Medicine, LMU Munich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Zoller, MD</last_name>
    <phone>+49894400</phone>
    <phone_ext>44111</phone_ext>
    <email>michael.zoller@med.uni-muenchen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dominik Hoechter, MD</last_name>
    <phone>+49894400</phone>
    <phone_ext>73410</phone_ext>
    <email>dhoechte@med.lmu.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Anesthesiology, LMU Munich</name>
      <address>
        <city>Munich</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Ziller, MD</last_name>
      <phone>+49894400</phone>
      <phone_ext>44111</phone_ext>
      <email>michael.zoller@med.uni-muenchen.de</email>
    </contact>
    <contact_backup>
      <last_name>Dominik Hoechter, MD</last_name>
      <phone>+49894400</phone>
      <phone_ext>73410</phone_ext>
      <email>dhoechte@med.lmu.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>August 11, 2018</study_first_submitted>
  <study_first_submitted_qc>August 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 22, 2018</study_first_posted>
  <last_update_submitted>February 20, 2020</last_update_submitted>
  <last_update_submitted_qc>February 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ludwig-Maximilians - University of Munich</investigator_affiliation>
    <investigator_full_name>Michael Zoller MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>ECMO</keyword>
  <keyword>haemostasis</keyword>
  <keyword>coagulation</keyword>
  <keyword>haemostatic alterations</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhagic Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>sharing individual participant data is restricted by EU General Data Protection Regulation (GDPR)</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

